Encompass Health Corporation filed its quarterly report on Form 10-Q with the U.S. Securities and Exchange Commission on August 7, 2026, covering the fiscal quarter ended June 30, 2026.

Key Highlights

  • Shares outstanding: The company reported 98,653,384 shares of common stock outstanding, net of treasury shares, as of July 28, 2026.
  • Exchange listing: Common stock, par value $0.01 per share, is listed on the New York Stock Exchange under the trading symbol EHC.
  • Filer status: Encompass Health is classified as a large accelerated filer under Exchange Act Rule 12b-2.
  • Reporting period: The quarterly report covers the period ended June 30, 2026, filed for Commission File Number 001-10315.
  • Compliance with filing requirements: The company confirmed it has filed all required reports during the preceding 12 months and has been subject to filing requirements for the past 90 days.

Encompass Health Q2 2026 Quarterly Disclosure: Key Details

Encompass Health Corporation, headquartered at 9001 Liberty Parkway, Birmingham, Alabama 35242, filed its Form 10-Q for the quarter ended June 30, 2026, with the SEC. The company, incorporated in Delaware with IRS Employer Identification Number 63-0860407, trades on the New York Stock Exchange (NYSE: EHC). As of July 28, 2026, the registrant reported 98,653,384 shares of common stock outstanding, net of treasury shares.

According to the filing, the quarterly report covers Part I Financial Information, including unaudited financial statements, Management's Discussion and Analysis of Financial Condition and Results of Operations, and Controls and Procedures. Part II addresses Other Information, including legal proceedings, risk factors, unregistered sales of equity securities, and exhibits. The company confirmed it has submitted all required Interactive Data Files electronically pursuant to Rule 405 of Regulation S-T.

The filing contains forward-looking statements, which the company identifies as subject to known and unknown risks. Per the filing, these statements "are necessarily estimates based upon current information and involve a number of risks and uncertainties, many of which are beyond our control." Disclosed risk areas include Medicare reimbursement changes, payor mix shifts, regulatory compliance burdens, audit exposure, and potential disruptions to Medicare and Medicaid operations resulting from federal government shutdowns. The company noted its concentration in inpatient rehabilitation and its dependence on Medicare regulations and reimbursement as a key risk factor.

What Was Disclosed

Encompass Health submitted its quarterly Form 10-Q for the period ended June 30, 2026, disclosing share count, filer classification, exchange listing details, and a range of operational and regulatory risk factors associated with its inpatient rehabilitation business.